Advanced Diagnostic Solutions for Precision Medicine
NABL-accredited laboratory offering 93 specialized diagnostic tests across 11 clinical specialties. From prenatal genetics to infectious disease detection, we provide accurate, timely results that guide critical healthcare decisions.
Comprehensive tumor profiling and hereditary cancer risk panels using advanced next-generation sequencing for precision oncology.
Targeted tumor profiling panel for solid-tumor somatic mutation analysis. Interrogates key cancer-driving genes and actionable variants to guide therapy selection and prognostic stratification.
Liquid-biopsy version of OncoFocus, optimized for circulating tumor DNA (ctDNA) analysis. Enables non-invasive mutation profiling and disease monitoring from plasma.
Broad-coverage tumor genomic profile assessing SNVs, indels, CNVs, and selected fusions across a large oncogene panel. Supports comprehensive biomarker discovery and therapy matching.
RNA-based NGS panel for detecting clinically relevant gene fusions and rearrangements in hematologic malignancies and solid tumors.
Germline panel for inherited cancer-predisposing genes across multiple hereditary cancer syndromes (e.g., BRCA1/2, Lynch, etc.).
Homologous recombination deficiency (HRD)-oriented panel assessing genomic instability,BRCA1/2 status, and related DNA-repair genes. Used for PARPi eligibility and genetic risk assessment.
Ultra-sensitive, patient-specific minimal residual disease (MRD) assay for tracking tumor-specific variants over time. Enables early detection of recurrence and treatment response monitoring.